|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Loss on disposal of assets | |||||
| Share-based compensation expense | |||||
| Deferred income taxes | |||||
| Amortization of operating lease right-of-use assets | |||||
| Impairment and abandonment of operating lease right-of-use assets related to facilities | |||||
| Impairment of internal-use and external-use software development costs, net | |||||
| Impairment of external-use software development costs | |||||
| Impairment of certain long-lived assets | |||||
| Inventory write-down | |||||
| Amortization of debt issuance costs | |||||
| Amortization of discount on convertible senior notes | |||||
| Gain on extinguishment of convertible senior notes, net | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable and unbilled receivables | |||||
| Inventories | |||||
| Prepaid expenses | |||||
| Other current assets | |||||
| Investment in sales-type leases | |||||
| Prepaid commissions | |||||
| Other long-term assets | |||||
| Accounts payable | |||||
| Accrued compensation | |||||
| Accrued liabilities | |||||
| Deferred revenues | |||||
| Operating lease liabilities | |||||
| Other long-term liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing Activities | |||||
| Asset acquisition | |||||
| External-use software development costs | |||||
| Purchases of property and equipment | |||||
| Business acquisitions, net of cash acquired | |||||
| Purchase price adjustments from business acquisitions | |||||
| Net cash used in investing activities | |||||
| Financing Activities | |||||
| Payments for debt issuance costs for revolving credit facility | |||||
| Repayment of convertible senior notes due 2025 | |||||
| Partial repurchase of convertible senior notes | |||||
| Purchase of convertible note hedge | |||||
| Partial unwind of convertible note hedge and warrants | |||||
| Proceeds from issuances under stock-based compensation plans | |||||
| Employees’ taxes paid related to restricted stock units | |||||
| Common stock repurchases | |||||
| Change in customer funds, net | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Cash, cash equivalents, and restricted cash at end of period | |||||
| Supplemental cash flow information: | |||||
| Cash paid for interest | |||||
| Income taxes paid, net of refunds received | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Unpaid purchases of property and equipment | |||||
| Transfers between inventory and property and equipment, net | |||||
| Excise tax payable on common stock repurchases | |||||
| Reconciliation of cash, cash equivalents, and restricted cash to the Consolidated Balance Sheets: | |||||
| Cash and cash equivalents | |||||
| Restricted cash included in other current assets | |||||
Loading...